ROYAL BANK OF CANADA - MYMD PHARMACEUTICALS INC ownership

MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 51 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 4.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MYMD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,00011,482
+7076.2%
0.00%
Q2 2023$0
-100.0%
160
-85.1%
0.00%
Q1 2023$2,0001,073
+158.6%
0.00%
Q4 2022$0
-100.0%
415
-82.0%
0.00%
Q3 2022$6,000
+100.0%
2,311
+295.0%
0.00%
Q1 2022$3,0000.0%585
+12.5%
0.00%
Q4 2021$3,000
-57.1%
520
-44.1%
0.00%
Q3 2021$7,0009300.00%
Other shareholders
MYMD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Shay Capital LLC 309,178$671,0000.14%
Taylor & Morgan Wealth Management, LLC 17,086$37,0000.04%
Ikarian Capital, LLC 81,089$176,0000.03%
Corundum Group, Inc. 19,600$43,0000.03%
M Holdings Securities, Inc. 70,909$154,0000.02%
Praetorian Wealth Management, Inc. 15,000$32,0000.01%
Western Wealth Management, LLC 27,050$115,0000.01%
Mirae Asset Global Investments Co., Ltd. 1,073,765$2,330,0000.01%
Virtu Financial LLC 16,063$35,0000.00%
SeaCrest Wealth Management, LLC 6,800$15,0000.00%
View complete list of MYMD PHARMACEUTICALS INC shareholders